Policy
In a Cabinet meeting, Health Secretary Robert F. Kennedy Jr. said the website could go live “probably in the next 10 days,” but an exact launch date remains unclear.
FEATURED STORIES
An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation threaten the U.S.’s half-century-long dominance in the biotech sector.
Acadia Pharma’s Catherine Owen Adams is one of the founders of a group of small- to mid-cap biotechs advocating against a ‘peanut butter blanket’ approach to drug pricing for small companies.
Former European Trade Commissioner Phil Hogan and former U.S. Senator Richard Burr, speaking on a panel at the J.P. Morgan Healthcare Conference, pushed to see a larger picture beyond the Trump administration’s year of chaos and confusion.
Subscribe to BioPharm Executive
Market insights and trending stories for biopharma leaders, in your inbox every Wednesday
THE LATEST
Orchard Therapeutics today announced that the European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to OTL-300, an investigational autologous ex vivo lentiviral gene therapy for the treatment of transfusion-dependent beta-thalassemia (TDBT), the most severe form of beta-thalassemia.
Sexual harassment has been a big focus in the news as of late, but much of this focus has been primarily concerned with the harassment issues in Hollywood and the political sphere. However, the scientific community has long been criticized for being a hostile environment for women as well.
Dr. Amin Al Amiri: the Programs are part of ministry’s initiatives during ‘Year of Zayed’ to provide quality of care to patients
Epigenomics AG today announced that the U.S. Congress urges the Centers of Medicare & Medicaid Services (CMS) to consider coverage of colorectal cancer screening blood tests as part of the approved 2019 Health and Human Services (HHS) Appropriations Bill.
Almac Group is pleased to announce the successful inspection of Almac Pharma Services (Ireland) at its European campus in Dundalk, Ireland, by the Health Products Regulatory Authority (HPRA).
In September OptiBiotix signs three more agreements
Certificate from AGES, the Austrian Agency for Health and Food Safety, endorses GMP conformity to Rentschler Fill Solutions’ new top-of-class facility.
Following the U.S. Drug Enforcement Agency’s rescheduling of GW Pharmaceuticals’ Epidiolex from a Schedule I to a Schedule V, other cannabis-based drug development companies believe there is momentum for their medications to gain regulatory approval.
Ministry presents initiatives at 12th International Law Enforcement Intellectual Property Crime Conference
One-year scheme under ATAA & TADAMON initiatives for financially challenged patients